These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27307535)

  • 1. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.
    Shah AA; Schiopu E; Chatterjee S; Csuka ME; Frech T; Goldberg A; Spiera R; Peng SL; McBride RJ; Cleveland JM; Steen V
    J Rheumatol; 2016 Sep; 43(9):1665-71. PubMed ID: 27307535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).
    Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA
    Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.
    Engel G; Rockson SG
    Vasc Med; 2005 Feb; 10(1):29-32. PubMed ID: 15920997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept study.
    Roustit M; Gaillard-Bigot F; Blaise S; Stanke-Labesque F; Cracowski C; Seinturier C; Jourdil JF; Imbert B; Carpentier PH; Cracowski JL
    Clin Pharmacol Ther; 2014 Apr; 95(4):439-45. PubMed ID: 24458011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion.
    Shah AA; Schiopu E; Hummers LK; Wade M; Phillips K; Anderson C; Wise R; Boin F; Seibold JR; Wigley F; Rollins KD
    Arthritis Res Ther; 2013 Apr; 15(2):R54. PubMed ID: 23597147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.
    Motegi SI; Sekiguchi A; Saito S; Ishibuchi H; Kishi C; Yasuda M; Ishikawa O
    J Dermatol; 2018 Mar; 45(3):349-352. PubMed ID: 29164658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 9. Treprostinil Hydrogel Iontophoresis in Systemic Sclerosis-Related Digital Skin Ulcers: A Safety Study.
    Guigui A; Mazet R; Blaise S; Cracowski C; Beau-Guillaumot M; Kotzki S; Roustit M; Cracowski JL
    J Clin Pharmacol; 2020 Jun; 60(6):758-767. PubMed ID: 32080862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic digital ulcers affect hand disability and pain in systemic sclerosis.
    Mouthon L; Carpentier PH; Lok C; Clerson P; Gressin V; Hachulla E; Bérezné A; Diot E; Khau Van Kien A; Jego P; Agard C; Duval-Modeste AB; Sparsa A; Puzenat E; Richard MA;
    J Rheumatol; 2014 Jul; 41(7):1317-23. PubMed ID: 24931950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis.
    Chung L; Fiorentino D
    J Am Acad Dermatol; 2006 May; 54(5):880-2. PubMed ID: 16635673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.
    Hachulla E; Clerson P; Launay D; Lambert M; Morell-Dubois S; Queyrel V; Hatron PY
    J Rheumatol; 2007 Dec; 34(12):2423-30. PubMed ID: 17985402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic literature review to inform the Portuguese recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases.
    Costa E; Cunha-Santos F; Dourado E; Oliveira D; Falzon L; Romão V; Duarte AC; Cordeiro A; Santiago T; Sepriano A
    ARP Rheumatol; 2024 Jul; 3(Apr-Jun):128-144. PubMed ID: 38306796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers.
    Nagaraja V; Spino C; Bush E; Tsou PS; Domsic RT; Lafyatis R; Frech T; Gordon JK; Steen VD; Khanna D
    Arthritis Res Ther; 2019 Sep; 21(1):202. PubMed ID: 31481106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.
    Ingegnoli F; Schioppo T; Allanore Y; Caporali R; Colaci M; Distler O; Furst DE; Hunzelmann N; Iannone F; Khanna D; Matucci-Cerinic M
    Semin Arthritis Rheum; 2019 Feb; 48(4):686-693. PubMed ID: 29706243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary Clinical and Laser Speckle Contrast Analysis Data on Selexipag Efficacy for the Treatment of Digital Vasculopathy in Systemic Sclerosis.
    Di Battista M; Della Rossa A; Da Rio M; De Mattia G; Morganti R; Mosca M
    J Rheumatol; 2023 Aug; 50(8):1029-1031. PubMed ID: 37003608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of iloprost in systemic sclerosis in a real-life experience.
    Bellando-Randone S; Bruni C; Lepri G; Fiori G; Bartoli F; Conforti ML; Moggi-Pignone A; Guiducci S; Giuggioli D; Colaci M; Spinella A; Ferri C; Matucci-Cerinic M
    Clin Rheumatol; 2018 May; 37(5):1249-1255. PubMed ID: 29470737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Data on Efficacy and Safety of Selexipag for Digital Systemic Sclerosis Vasculopathy.
    Di Battista M; Della Rossa A; Mosca M
    J Rheumatol; 2024 Sep; 51(9):899-903. PubMed ID: 38879188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raynaud, digital ulcers and calcinosis in scleroderma.
    Nitsche A
    Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital ulcers: overt vascular disease in systemic sclerosis.
    Steen V; Denton CP; Pope JE; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.